Exploring mechanisms of fatigue during repeated exercise and the dose dependent effects of carbohydrate and protein ingestion: study protocol for a randomised controlled trial by Abdullah F Alghannam et al.
TRIALS
Alghannam et al. Trials 2014, 15:95
http://www.trialsjournal.com/content/15/1/95STUDY PROTOCOL Open AccessExploring mechanisms of fatigue during repeated
exercise and the dose dependent effects of
carbohydrate and protein ingestion: study
protocol for a randomised controlled trial
Abdullah F Alghannam1*, Kostas Tsintzas2, Dylan Thompson1, James Bilzon1 and James A Betts1Abstract
Background: Muscle glycogen has been well established as the primary metabolic energy substrate during physical
exercise of moderate- to high-intensity and has accordingly been implicated as a limiting factor when such activity is
sustained for a prolonged duration. However, the role of this substrate during repeated exercise after limited recovery is
less clear, with ongoing debate regarding how recovery processes can best be supported via nutritional intervention.
The aim of this project is to examine the causes of fatigue during repeated exercise bouts via manipulation of glycogen
availability through nutritional intervention, thus simultaneously informing aspects of the optimal feeding strategy for
recovery from prolonged exercise.
Methods/Design: The project involves two phases with each involving two treatment arms administered in a
repeated measures design. For each treatment, participants will be required to exercise to the point of volitional
exhaustion on a motorised treadmill at 70% of previously determined maximal oxygen uptake, before a four hour
recovery period in which participants will be prescribed solutions providing 1.2 grams of sucrose per kilogram of body
mass per hour of recovery (g.kg−1.h−1) relative to either a lower rate of sucrose ingestion (that is, 0.3 g.kg−1. h−1; Phase I)
or a moderate dose (that is, 0.8 g.kg−1.h−1) rendered isocaloric via the addition of 0.4 g.kg−1.h−1 whey protein
hydrolysate (Phase II); the latter administered in a double blind manner as part of a randomised and counterbalanced
design. Muscle biopsies will be sampled at the beginning and end of recovery for determination of muscle glycogen
resynthesis rates, with further biopsies taken following a second bout of exhaustive exercise to determine differences in
substrate availability relative to the initial sample taken following the first exercise bout.
Discussion: Phase I will inform whether a dose–response relationship exists between carbohydrate ingestion rate and
muscle glycogen availability and/or the subsequent capacity for physical exercise. Phase II will determine whether such
effects are dependent on glycogen availability per se or energy intake, potentially via protein mediated mechanisms.
Trial registration: ISRCTN87937960.
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It is well established that during prolonged moderate to
high intensity exercise, carbohydrate is primarily utilised
to support energy metabolism due to its efficiency and
expeditious availability to support the energetic require-
ments of such activities [1-3]. In humans, the majority of
endogenous carbohydrate is stored as glycogen in the
muscle and liver [4] with the capacity to sustain muscle
contractions at the aforementioned exercise intensities
being highly dependent on the availability of this glycogen
at these sites [5,6]. The physiological mechanisms respon-
sible for these observations appear to involve several inter-
related factors including: maintenance of euglycaemia and
an attenuation of central nervous system fatigue; glycogen
sparing; and reduced exercise-induced strain [7].
Recovery following exercise is mainly determined by the
time required to replenish the depleted glycogen stores
and ingesting sufficient carbohydrate (6 to 10 grams of
carbohydrate per kilogram of body mass per day) is neces-
sary to restore both glycogen depots and the capacity for
repeated physical exertion [8-10]. Conversely, when pe-
riods of recovery are limited (≤8 hours), such as various
training and competition scenarios, neither of the afore-
mentioned processes can be entirely restored [11]. This un-
derpins the importance of identifying nutritional strategies
to maximise recovery and restoration of exercise capacity
in concurrence with manifestations of fatigue during a
repeated exercise bout. To date, nutritional research con-
cerning recovery from exercise has been based on the
assumption that similar fatigue mechanisms will operate
during repeated exercise within hours of an initial bout, so
has understandably focused on strategies to accelerate
muscle glycogen resynthesis. While much is now known
about the amount, type and timing of nutrient intake that
can facilitate muscle glycogen storage and/or the capacity
for repeated physical exertion [11], little evidence exists to
demonstrate a link between these variables.
When examining these variables independently, it ap-
pears that muscle glycogen resytnhesis is augmented during
recovery as opposed to a placebo [12,13] and a dose–re-
sponse relationship exists between carbohydrate intake and
muscle glycogen resynthesis until reaching a threshold of
1.2 grams per kilogram of body mass per hour of recovery
(g.kg−1.h−1) [11]. In addition to the amount of carbohydrate
provided, muscle glycogen storage is primarily influenced
by the energy content irrespective of the macronutrient
composition [14]. Consequently, the glycogenic properties
of carbohydrate may be related to the increased energy
content or mediated metabolic responses (hyperinsulinae-
mia) rather than the presence of carbohydrate fraction per
se. Therefore, several studies were implemented to explore
the efficacy of mixed macronutrient ingestion during recov-
ery and repeated exercise, particularly carbohydrate-protein
supplementation [15]. The culmination of the resultssuggests that increasing the amount of carbohydrate is
sufficient to maximise glycogen resynthesis rates and re-
store endurance capacity more completely [11], although
some indicate a distinct advantage of protein co-ingestion
[16-18]. Further investigation is required, particularly
during running-based exercise, to elucidate the efficacy of
protein co-ingestion on restoration of muscle glycogen
during limited recovery and the potential ergogenic effects
upon subsequent endurance capacity.
Based on the above information, increasing carbohy-
drate intake during short-term recovery can accelerate
muscle glycogen resynthesis. Nevertheless, endurance
capacity may not concurrently improve [19,20]. Only one
investigation reported an enhanced capacity for repeated
exercise following limited recovery in response to higher
carbohydrate intake [21]. Few investigations have been
conducted to examine the role of muscle glycogen during
a subsequent exercise bout [17,22,23], and none examined
muscle glycogen degradation during a repeated exhaustive
exercise bout. In accordance, glycogen availability may not
play a fundamental role in contrast to an initial exercise
bout whereby fatigue is intimately associated with glyco-
gen depletion [5]. Different fatigue mechanisms may take
place, and muscle glycogen metabolism during a subse-
quent exhaustive exercise bout following short-term
recovery remains to be examined.
Trial objectives
This research trial will investigate the relationships be-
tween carbohydrate intake, muscle glycogen metabolism
and exercise capacity during a repeated bout of physical
exercise. It will explore whether the effect of carbohydrate
ingestion is causal between muscle glycogen availability
and/or endurance capacity, and if this relationship is
linked to the carbohydrate fraction per se or simply to an
energy intake surplus. Thus, a replacement of a fraction of
the carbohydrate with a different macronutrient (whey
protein hydrolysate) matched in energy content will be ex-
amined to assess if whey protein hydrolysate co-ingestion
provides a distinct benefit over carbohydrates alone in
relation to muscle glycogen storage and/or the capacity
for subsequent exercise. Specifically, we aim to accomplish
the following objectives: (i) to examine whether a dose–
response relationship exists between rates of carbohydrate
(sucrose) ingestion and muscle glycogen availability follow-
ing short-term recovery and/or the capacity for subsequent
exercise; and (ii) to explore the potential protein-mediated
effects upon muscle glycogen resynthesis and/or the cap-
acity for a subsequent exercise bout with the ingestion of
whey protein hydrolysate.
The use of the disaccharide sucrose was chosen on
the basis of its potential positive contribution to liver
and/or muscle glycogen resynthesis by virtue of equi-
molar amounts of glucose and fructose. Following
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elicit similar muscle glycogen resynthesis rates [24]. How-
ever, resting intravenous [25,26] and oral ingestion [27]
studies indicate that fructose preferentially stores liver
glycogen relative to glucose, while glucose infusion favours
muscle glycogen resynthesis. Given the importance of both
liver and muscle glycogen replenishment during short-term
recovery and subsequent endurance capacity [28], sucrose
was deemed a preferable source of carbohydrate to undergo
predominant hepatic metabolism (that is, fructose) to opti-
mise liver glycogen resynthesis alongside a glucose source
to maximise muscle glycogen storage [29].
An important factor determining the rate of muscle
glycogen resynthesis is insulin-mediated glucose uptake
by the muscle cells [8]. A proposed mechanism for the
potential benefit of protein co-ingestion in enhancing
the rate of glycogen storage is the synergistic effect of
this substrate on insulin secretion [30,31]. It has been
recently demonstrated that plasma insulin response
increases to a greater extent in whey than in casein
protein in its intact form [32]. The ingestion of a protein
hydrolysate accelerates digestion and absorption com-
pared with its intact protein, resulting in a more rapid
increase in circulating insulin concentrations [33]. This
was further confirmed by the finding of greater insulino-
tropic properties when whey protein hydrolysate was
ingested as opposed to whey protein in humans [34].
Concerning glycogen storage, the ingestion of whey
protein has been shown to stimulate this process more
rapidly both in liver and skeletal muscle tissues than
when casein was ingested [35]. Furthermore, it appears
that ingesting whey protein hydrolysate with carbohy-
drate augments glycogen resynthesis to a greater extent
than when carbohydrate is co-ingested with intact whey
protein, casein or intact branched-chain amino acids
[36]. Taken together, these results indicate that a hydro-
lysed whey protein fraction may have a profound role in
stimulating insulin secretion and concomitant muscle
glycogen storage, and thus forming the basis for the
inclusion of this protein fraction in the current study.
Trial design
The methods described here stem from a wider project ti-
tled ‘Macronutrient ingestion, Muscle glycogen and Post-
Exercise Recovery’. Both trial phases described herein have
been approved by the National Health Service (NHS) South
West 3 Research Ethics Committee (REC) with an allocated
reference number: 09/H0101/82. The project was subse-
quently registered as a clinical controlled trial (ISRCTN
87937960).
Phase I of testing will address objective (i) by way of a
non-randomised repeated measures design. The chosen
trial design for Phase I is based on the premise that a
lower rate of sucrose ingestion will mediate sub-optimalrecovery, thus resulting in impairment in exercise cap-
acity relative to a higher rate of sucrose intake, as has been
previously reported in a similar investigation [21]. It was,
therefore, assumed that participants would run longer
when the higher sucrose treatment was administered. Ac-
cordingly, a non-randomised design would allow not only
an investigation of the metabolic environment at the point
of fatigue during the low versus high sucrose treatments,
but also at the time point in the high sucrose treatment
coincident with the onset of fatigue during low sucrose
treatment. Indeed, previous studies have adopted a
similar approach to investigate mechanisms through
which carbohydrate supplementation enhances the cap-
acity for both cycling [37] and running [38] modes of
exercise. In addition, participants will be fully familiarised
with a trial (see experimental protocol) that will be identi-
cal to the main procedures and, therefore, diminishing any
order effects. This will consequently improve the reliability
of the performance measure that would enable the detec-
tion of small but worthwhile intervention effects [39].
The second phase (Phase II) of testing will address
objective (ii) by adopting a randomised double-blind
cross-over experimental design.
Methods/Design
Ethical considerations and safety
The individuals who agree to participate following the brief-
ing will be provided with an informed consent form, indi-
cating their full understanding of the study and their
protected rights for confidentiality and withdrawal from the
study without giving a reason. Thereafter, a compulsory
medical health questionnaire will be completed by each
participant to ensure the absence of any physical, haemato-
logic, metabolic or any other health conditions deemed to
pose a risk to the participant or bias towards the investiga-
tion. If any of the factors above were present, the volunteer
would be deemed unfit to participate in the study and
would consequently be excluded from taking part. Further
health questionnaires and profile of mood state (POMS)
questionnaire will be completed before each trial to ensure
that participants are fit and able to take part in testing and
to establish similar physical and mental engagements
throughout the trials.
Experimental design
The global design of the trial includes comparisons of two
nutritional interventions during each distinct phase of
testing. A minimum of two weeks wash-out period will be
allowed between each main trial to avoid any carry-over
effects. The independent variable will be the precise nutri-
tional intervention applied during the short-term recovery
period. This involves the provision of 0.3 g.kg−1.h−1 and
1.2 g.kg−1.h−1 of carbohydrate in the form of sucrose solu-
tions in Phase I of testing and a 1.2 g.kg−1.h−1 sucrose
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tein hydrolysate in Phase II of the project. All treatments
will be provided in equal volumes (10 ml.kg−1.h−1) and will
be matched in sodium and potassium composition. The
test beverages will also be matched in flavour (vanilla ex-
tract). Sample analyses of both treatments underwent
screening by an independent institution (HFL Sport Sci-
ence, LGC Ltd., Teddington, Middlesex, UK) to confirm
the absence of any contaminants such as banned anabolic
steroids and stimulants including noradrenaline, Tetrahy-
drogestrinone (THG) and 3,4-methylenedioxymetham-
phetamine (MDMA). A full description of the treatment
composition is provided in Table 1.
To assess human endurance capacity, the trial adopted
an exercise time to exhaustion (TTE) as an outcome
measure. Although it has been argued that time-trial (TT)
is more relevant than TTE as performance measure, these
theories are based on the assumption that the primary
outcome variable is a reflection of what occurs during ac-
tual sporting performance. These assumptions are gener-
ally founded on two factors: (1) there are no real-world
sporting events that are the equivalent of TTE, which
require an individual to run until the point of exhaustion;
and (2) TTE appears to be less reliable than TT in relation
to a valid simulation that resembles actual performance in
a given sport [40]. While applied sports science studies
mimic ‘real-world’ sporting events and provide a useful
tool in assessing performance in a sports context, this
naturally constrains them to the rules and regulations of a
given sport that may be changed or refined periodically.
If we wish to interpret the value of performance measures
in ‘real-world’ events, TTE may arguably be more prevalent
and have a more important bearing in the broader scale. In
terms of prevalence, there are clearly more recreational
exercisers than athletes, who may present a case thatTable 1 Nutritional information of the supplements





Moderate sucrose + whey
protein hydrolysate
Sucrose (g/L) 30 120 80
Lactose (g/L) - - ≤3.5a
Protein (g/L) - - 40
Fat (g/L) - - ≤2.2a
Sodium (g/L) 0.38 0.38 0.38
Potassium (g/L) 0.47 0.47 0.47
Calcium (g/L) - - 0.2
Magnesium (g/L) - - 0.01
Phosphorous (g/L) - - 0.12
Chloride (g/L) - - 0.15
Energy (kcal/L) 120 480 480
aAssay unable to detect values below this number. The caloric content for fat
and lactose was therefore assumed negligible.maintaining their running or cycling endurance capacities
to be able to engage with other exercisers at the same
intensity and for the duration of the activity (such as
running outdoors with friends or maintaining the capacity
to complete a 90 minute football match) is paramount.
Furthermore, many athletes undertake exercise scenarios
similar to TTE tests. For example, pace is often set by the
fastest athlete with the majority of athletes attempting to
sustain this pace for as long as possible before reducing
their pace and consequently falling behind the group/
athlete. With regard to importance, endurance capabilities
defined as ‘the ability of a muscle group to sustain external
forces for long periods of time’ are considered an integral
component in improving the occupational tasks of military
personnel [41]. This underscores the importance of endur-
ance capacity over performance time in this population
whereby completing a march as a unit is the goal and not
performance at maximal individual capabilities of a set task,
which could separate individuals and pose risks for those
personnel. Certainly, scientific investigations that measure
constants in nature (that is, establishing the mechanisms of
fatigue) should not be overlooked.
It should also be recognised that TTE measures vary
widely in the literature and the actual reliability will depend
on the protocol, individual and laboratory environment
and, critically, familiarisation should not be viewed as a ‘one
size fits all’ view. Given the importance of familiarisation, it
is acknowledged that TT carry greater reliability from the
outset, particularly if using relevant athletes and repetitive
familiarisation with TTE is to be avoided. However, we have
demonstrated in our current project sufficient reliability
(CV = 3.5%, based on TTE during the first run to exhaus-
tion between trials) when participants are familiarised and
attempts are made to help them gauge their level of fatigue
(that is, use of our three-strikes run-walk-run approach to
achieve a metabolic end point). Taken together, TTE
measures in endurance-trained athletes who are familiarised
with the protocol are adequate to elicit reliable and sensitive
measures.
The view that TT is a better representation of human
performance is of course a valid one, if the sole reason for
a performance measure is to produce an outcome measure
that can be directly extrapolated to a real-world event.
Nonetheless, it should be appreciated that a large number
of scientific investigations involve mechanistic variables of
human performance and its limitations, be it physiological,
metabolic or neuromuscular among others. Fatigue is a
complex phenomenon with several contributing factors,
such that fatigue may occur simultaneously in several loci
in the human body with the relative underlying mecha-
nisms likely to overlap and interact [42,43]. It is imperative,
therefore, that to investigate this intricate behaviour, means
of inducing volitional fatigue through TTE performance
measures are important to be included in a controlled
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ance limitations and the possible mediating influences of
certain nutritional interventions in delaying the onset
of fatigue in humans. Accordingly, given that the aims of
the current project are mechanistic in nature provides a
foundation for the adopted TTE outcome measure.
Participants
The chosen target population for the research trial will be
healthy non-smoking recreationally active men and
women who include endurance training in the form of
running as a central component (≥2 hours/week) of their
training regime. The chosen age range for participation
will be 18 to 48 years old. The research trial aims to
recruit sixteen participants (eight in each phase of testing)
from the University of Bath campus and surrounding
sporting clubs by way of public advertisement and per-
sonal communication. These individuals will all be trained
(as evidenced both by their self-reported training volume
and also measures of maximal oxygen uptake during
preliminary testing). Upon volunteering, the participants
will be initially briefed in writing followed by a verbal
explanation of the protocol and the pre-requisites set for
satisfactory inclusion on their first visit to the laboratories
to ensure their full understanding before the investigation.
The target population sample will be free from any condi-
tion that either poses undue personal risk or introduces
bias into the experiment (as determined by each partici-
pant’s responses to baseline health screening). In relation
to eumenorrheic female participants, all measurements
will be conducted at least three and at most ten days after
the onset of menses (that is, the follicular phase) to ensure
low levels of circulating female hormones and, therefore,
minimise any measurement errors associated with the
menstrual cycle. Each participant will be required to at-
tend the Physiology Research Laboratory at the University
of Bath on four occasions. These include: (i) a preliminary
visit; (ii) a familiarisation visit; and (iii) two main trials
completed on separate days.
Control measures
Standardisation of lifestyle
Over the 48 hours prior to the familiarisation trial, a
weighed dietary record will be completed for the ana-
lysis of macronutrient composition and total daily en-
ergy intake. The same diet will then be replicated prior
to any laboratory visit involving the main procedures.
Participants will be required to abstain from alcohol
consumption for 24 hours before any trial, while
caffeine abstinence will be started at 17:00 on the day
preceding any trial. The latter aims mainly to avoid any
unnecessary side effects that may negatively influence
performance as a result of adverse withdrawal from
caffeine [44]. Approximately 12 hours before thefamiliarisation session and, subsequently, before the ex-
perimental trials, a standardised meal will be provided
for each participant. This is aimed at minimising any
within-subject variability in the nutritional status of
each participant that is known to influence metabolism
and exercise performance and, ultimately, may influence
the outcomes of the study [44,45].
Participants will be required to complete an activity
log in conjunction with their dietary control procedures
discussed in the experimental protocol. The participants
will be instructed to refrain from any strenuous physical
training for 48 hours before any trial with any light-to
moderate habitual training recorded for time, duration
and mode of exercise before the familiarisation session.
This procedure will be matched for ensuing trials. Stand-
ardisation of lifestyle will be retrospectively analysed for
nutritional intake (via nutritional assessment software)
and activity (minutes of exercise per day) to ensure suffi-
cient control over the testing period.
Environmental measurements
Ambient temperature, humidity and barometric pres-
sure will be monitored and recorded at 60 minute inter-
vals throughout the trials using a portable weather
station (WS 6730; Technoline, Berlin, Germany). The
latter will be used to record atmospheric pressure to
allow for corrections to standard volumes during
expired gas analysis.
Experimental protocol
Upon arrival in the laboratory on the day of familiarisa-
tion and each main trial, participants will have fasted
for a period of ≥10 hours. Participants will then provide
further written confirmation of their consent to take
part, before completing an assessment of their mood
state. A baseline urine sample will be collected from the
first void of the day (30 minutes prior to testing) to
ensure adequate hydration followed by a baseline
assessment of body mass. Thereafter, participants will
be placed in a semi-supine position before a five minute
resting sample of expired gases is collected using the
Douglas Bag technique [46]. An indwelling cannula will
then be fitted to an antecubital vein and a 10 ml base-
line blood sample collected, with the cannula kept pa-
tent throughout trials by frequent flushing with isotonic
saline. Participants will then begin running on the
treadmill with a standardised five minute warm-up at
60% of maximal oxygen uptake ( VO2max ) before the inten-
sity will be increased to 70% VO2max, which will be sustained
until volitional exhaustion. To gauge their relative levels of
fatigue accurately, participants will be permitted to reduce
the intensity (walking at 4.4 km.h−1) for two minute inter-
vals on two occasions when they indicate they can no
longer sustain the running speed. A 2 ml venous blood
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followed by a return to the prescribed running speed at
70% VO2max . Volitional exhaustion will be accepted on the
third occasion when participants indicate they are unable
to exercise at the prescribed running intensity, and TTE
will be recorded (excluding the time permitted for walk-
ing). To ensure the attainment of a metabolic endpoint, at
least one of the predetermined criteria must be observed:
(1) a reduction in blood glucose concentration below
3.9 mmol.L−1 and/or (2) the inability to sustain exercise
following walking on two occasions. This is aimed at en-
suring similar liver glycogen depletion levels during
treatments and, thus, reducing the variability in carbo-
hydrate availability during recovery. Immediately after
this first run, participants will rest in a semi-supine
position while a 3 to 5 mm skin incision will be made
to the anterior portion of the thigh under local anaes-
thetic and a muscle biopsy obtained from the vastus
lateralis using the percutaneous needle biopsy tech-
nique. This biopsy will be obtained in all treatment arms
of the research project with the exception of the high
sucrose treatment in Phase I. The biopsy will be utilised to
compare possible mechanisms of fatigue during the subse-
quent bout of exercise between low and high sucrose
treatments (further details provided below).
At this point the four hour post-exercise recovery will
commence with the first volume of prescribed solution
(10 ml.kg−1.h−1) ingested as soon as the first muscle biopsy
has been removed from the leg, with the remaining seven
aliquots provided at 30 minute intervals during the ensu-
ing recovery. Participants will be permitted 15 minutes to
consume each volume such that feeding will be complete
15 minutes prior to the second muscle biopsy. Expired gas
and venous blood samples will be taken during the recov-
ery period every hour prior to feedings. In addition, each
participant’s total urine output will be collected during the
recovery period and stored in a vessel containing 5 ml
10% thymol isopropanol as a preservative. Approximately
20 minutes prior to the end of recovery, a further two to
three separate skin incisions will be made to the same leg
and the second muscle biopsy will be sampled at four
hours following the first sample. The remaining incision
site(s) will then be available for further biopsies during/
after the second exercise bout.
After the standardised warm-up, participants will again
run on the treadmill at 70% VO2max until the point of vol-
itional exhaustion. The achievement of a metabolic end-
point will be determined in a similar manner to the initial
exercise bout. As in the first run, water intake will be ad
libitum during the familiarisation trial and matched for
the ensuing main trials. Blood will be obtained every
10 minutes for the first 30 minutes and at the point of
volitional fatigue. Expired gas samples will be collected at
15 minute intervals and at the point of fatigue (that is, afinal minute expired gas sample). In relation to Phase I, it
is highly likely that all participants will exercise for longer
in their second trial (that is, with the 1.2 g.kg−1.h−1 sucrose
solution), so the exercise test will be briefly interrupted for
an additional muscle biopsy at the point where fatigue
occurred in each participant’s first trial (that is, with the
0.3 g.kg−1.h−1 sucrose solution). A further blood and gas
sample will also be obtained during this time point to
investigate the metabolic environment across treatments.
Final blood and gas samples will be taken within the final
minute of exercise and the remaining biopsy site will be
used to obtain a post-exercise muscle sample. The three
biopsies taken in any given trial will be sampled from the
same leg, each separated by approximately 3 cm, with the
use of dominant/non-dominant legs being counterba-
lanced between trials.Measures
Anthropometry
The determination of post-void nude body mass for the
participants will be recorded on their first visit to the la-
boratory to allow for an accurate nutrient provision dur-
ing subsequent visits that are calculated relative to each
participant’s body mass. Measurements of body mass
will also be required pre- and post-exercise on all ensu-
ing visits to assess the hydration status of each partici-
pant via the recordings of the difference in nude body
mass (reported as percentage difference) at the begin-
ning and end of an exercise session. Weighing of each
participant’s body mass will be undertaken by using a
balance scale, where participants will be asked to stand
in the centre of the platform while standing aligned with
their weight evenly distributed on both feet. Measure-
ment of the stature of the participants will be recorded
by using a stadiometer. The participants will be re-
quested to remove any footwear and to hang their arms
freely with the palms facing the thighs and heels. It will
be ensured that the gluteal area and shoulders make
contact with the stadiometer to maintain sufficient align-
ment. To achieve accurate measurements, participants
will be verbally advised to stand up straight while facing
directly with the head in the Frankfort plane (orbitale
and tragion are horizontally aligned). The participant
inspires for measurement, and the recorder brings down
the headboard to compress the hair [47]. From the col-
lective measurements obtained above, body mass index
can be determined (kg.m−2) for each participant.Preliminary measurements
The preliminary tests to be administered will require
approximately 60 to 90 minutes and involve an assessment
of running economy (that is, VO2.km
−1) and VO2max
[48]. These tests initially require participants to run on
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Rhein, Germany). The protocol involves a standardised
five minute warm-up that consists of jogging at a speed of
7.5 km.h−1, followed by a running economy test. This
requires participants to run at various sub-maximal speeds
with increments of 1 km.h−1 to enable a minimum of four
different running speeds. Each running speed will consist
of three minute stages, during which expired gas, heart
rate (HR) and ratings of perceived exertion (RPE) will be
recorded at the final minute of each stage. Expired gas,
HR and RPE will be obtained via the Douglas bag method,
short range telemetry (FT2, Kempele, Finland) and Borg’s
(6 to 20) scale [49], respectively.
Approximately 20 minutes following the sub-maximal
test, a run time to volitional exhaustion will be initiated
to determine relative values for participants. The speed
for this test will be determined from the data acquired
from sub-maximal running that would reflect a speed
corresponding to 85% of maximum heart rate. The cal-
culated speed will be kept constant throughout the test.
The initial gradient will be set at 3.5% and increased
with increments of 2.5% following the end of each run-
ning stage. Furthermore, the duration of each running
stage (three minutes) and collection points (final minute
of each stage) of expired air, HR and RPE will be kept
identical to the sub-maximal testing. The final collection
point of data is the point of volitional exhaustion, which
is defined as the final minute to be able to sustain a
given running speed indicated by the participant. A final
minute expired gas sample will be collected at this time
point. Satisfactory achievement of VO2max will be ful-
filled on the bases of the observation of three of the cri-
teria of the British Association of Sport and Exercise
Sciences for establishing maximal oxygen uptake in adult
subjects [50]. These include the attainment of a maximal
heart rate within 10 beats.min−1 from the predicted
heart rate maximum for participants (220 beats.min−1 -
age), respiratory exchange ratio (RER) values of ≥1.1 and
subjective indication of volitional exhaustion as indi-
cated by the participant on the RPE scale. The data
acquired from these tests can then be used to calculate
the treadmill speeds that elicit 60% and 70% VO2max ,
which will be required during warm-up and running
procedures in the main trials, respectively.Familiarisation
The participants will be required to complete a familiarisa-
tion session at least two weeks prior to their main trials.
The familiarisation visit will involve participants complet-
ing the main exercise protocol procedures to be per-
formed during the trial (described in the experimental
protocol) but without any collection of tissue samples.
This visit, therefore, allows participants to familiarise withthe study procedures and, thus, diminish any learning/
trial-order effects. This visit will also enable us to confirm
that the calculated running speeds reflect the required in-
tensity (that is, 60% and 70% VO2max ) during the trial,
with any adjustments to speed deemed by expired gas data
being applied accordingly.Physiological measurements
Urine output
Baseline urine samples will have been obtained 30 minutes
before testing to determine hydration via the freezing point
depression method by using a cryoscopic osmometer
(Advanced Instruments, Inc, Norwood, MA, USA). The
threshold for adequate hydration will be assumed for
osmolality values ≤900 mOsm.kg−1 [51]. During the four
hour recovery period, the voided urine will be collected in a
vessel containing a preservative (5 ml of 10% thymol
isopropanol). Upon recording total urine output during this
period, a mixed 1 ml sample will be taken and stored
at −80°C to enable the estimation of total urinary urea
nitrogen excretion, which will subsequently be corrected
with plasma urea for whole-body determination of the
urea pool during recovery [52]. Non-protein respira-
tory exchange ratios (NPRER) will also be calculated
to reflect protein oxidation rates during the four hour
recovery phase [53].Expired gas sampling
Expired gas samples will be obtained via the Douglas
bag method (Hans Rudolph, Shawnee, KS, USA) from
each participant. A respiratory valve with a mouth piece
will be attached to a 200 litre Douglas bag for expired
gas sampling, which will be provided with a nose clip to
participants approximately 30 seconds before sampling
to remove any residual atmospheric air from the valves.
The collected gas samples will then be analysed for rela-
tive expired fractions of oxygen and carbon dioxide
using paramagnetic and infra-red analysers, respectively
(Servomex, Crowborough, UK). The total volume of
expired gas within the Douglas bag will subsequently be
measured by a dry gas meter (Harvard Apparatus, Kent,
UK), with the temperature of expired gases being col-
lected at the time of evacuation by a thermistor probe.
Prior to any gas collection, calibration of equipment will
be conducted using gas cylinders containing specific gases
with a known relative composition (N2 = 0%; O2 = 16.9%;
CO2 = 4.93%), as validated by the manufacturer (CryoService,
Worcester, UK). Each analyser will then be validated against
atmospheric air. The inspired air will be measured proxim-
ally to the participants throughout the studies, with values
used relative to each corresponding expired gas sample to
minimise systematic bias associated with assumptions that
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pheric constants [54].
The calculations of oxygen consumption and carbon
dioxide production from each bag will then be used for
the determination of carbohydrate and lipid oxidation
rates (g.min−1) using the following formulae:
Carbohydrate Oxidation ¼ 4:212  VCO2ð Þ−ð3:005  VO2 Þ−ð2:449  NÞ
Fatty Acid Oxidation ¼ 1:754  VO2ð Þ− 1:754  VCO2Þ−ð2:017  NÞð
Where N is the estimated rate of nitrogen excretion
based on urinary/plasma urea [52].
Extramuscular carbohydrate oxidation can then be
derived from the difference between whole-body carbohy-
drate oxidation as determined from indirect calorimetry
and intramuscular carbohydrate oxidation methods (over-
all muscle glycogen degradation rates).
Blood sampling
During the familiarisation session, blood samples will
have been obtained using the capillary fingertip method
by a 3 mm puncture (Accu-Check; Roche Diagnostics
GmbH, Mannheim, Germany) applied distally relative to
each participant’s fingers. These will be dispensed into
microvettes (approximately 25 μl) containing lithium
heparin to act as an anticoagulant before being analysed
for blood glucose and ketone body concentrations
(Optium Xceed; Abbott Laboratories Ltd., Maidenhead,
UK). Venous blood samples will have been obtained dur-
ing the main trials via an indwelling cannula; inserted into
an antecubital vein under local anaesthesia (1% lidocaine;
Hameln Pharmaceuticals Ltd., Brockworth, UK) and kept
patent throughout the trials by flushing with heparin-free
isotonic saline (B. Braun, Melsungen, Germany) following
each sampling point. Participants will be rested in a semi-
supine position for 10 minutes prior to any baseline blood
sample. A 10 ml blood sample will be collected during
each sampling point before being dispensed into 2 × 5 ml
tubes. Each blood sample will first be transferred into a
non-anticoagulant collection tube (Sarstedt, Leicester,
UK), and left to clot for approximately 45 minutes at room
temperature before centrifugation at 2000 × g for 10 mi-
nutes at 4°C (Heraeus Primo R; Thermo Fisher Scientific,
Loughborough, UK) for serum extraction, which will be
stored at −80°C pending analysis for insulin concentration.
The remaining 5 ml of each venous blood sample will be
dispensed into a different tube containing an anti-
coagulant (ethylenediaminetetraacetic acid; EDTA) then
immediately analysed for haemoglobin concentrations by
using an automated haematology analyser (Sysmex SF-
3000; Sysmex Ltd., Wymbush, UK). Thereafter, 3 × 50 μl al-
iquots of blood will be removed using micro-haematocrit
tubes and subsequently centrifuged (Hawksley, Lancing,
UK) to obtain haematocrit concentrations. Equations based
on heamoglobin and haematocrit values will be utilised todetermine plasma volume changes throughout the trials
[55]. The remaining EDTA-treated blood will then be spun
for centrifugation under 2000 x g for 10 minutes at 4°C for
plasma extraction prior to being stored at −80°C for later
analysis of plasma glucose, lactate, non-esterified fatty acids
and urea.
Plasma glucose, lactate, non-esterified fatty acids and urea
For the assessment of plasma metabolites, an automated
spectrophotometric analyser (RX Daytona, Randox,
Crumlin, Ireland) will be utilised. Prior to each sample
analysis a calibration will be conducted and quality control
will be checked against the manufacturer’s available
standards.
Serum insulin
Sera concentrations will be assessed by enzyme-linked
immunosorbent assays (ELISA) using a spectrophoto-
metric plate reader. The fundamental principle of all
these assays is that the target analyte (the antigen) is
recognised with high specificity by antibodies within the
human body. The immune system produces antibodies
in response to the presence of antigens. These antibodies
subsequently recognise and bind to the antigens, and the
labeling of the resultant bound antibody forms the basis
of this method [56].
Muscle biopsy sampling and storage
To minimise discomfort for participants while obtaining
muscle samples at essential time points for the aims of
the study, three muscle biopsy samples will be obtained
during each main trial. In Phase I and during the low
sucrose treatment arm, a muscle biopsy sample will be
taken at the point of volitional exhaustion following the
first exercise bout to identify muscle glycogen depletion
levels before the short-term recovery period. Indeed,
given that participants had consumed replicate diets
48 hours prior to each main trial and the provision of a
standerdised final meal (see standardisation of lifestyle
section), and were required to run to volitional exhaus-
tion suggests that muscle glycogen levels are expected to
be similar between any of the first exhaustive exercise
bouts during the main trials. Based on previously reported
data that applied a similar dietary and activity standardisa-
tion in addition to comparable exercise protocol proce-
dures, it was shown that muscle glycogen depletion levels
were unlikely to vary between trials [38]. Hereafter, a bi-
opsy sample will not be required at this time point during
the high sucrose trial. Further support of this is gained
through the initial run times to exhaustion obtained from
participants tested thus far in Phase I, indicating compar-
able times to exhaustion (data not shown) and, thus,
endorsing the notion that intra-individual pre- and post-
exercise muscle glycogen contents were at comparable
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ples in the low sucrose treatment will be obtained at the
end of recovery and at the point of fatigue during the sub-
sequent run. During the high sucrose treatment, the three
muscle tissue samples will be obtained at the end of the
recovery period, the time corresponding to fatigue during
the low sucrose treatment and at the point of volitional
exhaustion during the subsequent run.
It is difficult to ascertain the condition under which
muscle glycogen storage and/or endurance capacity may be
enhanced in Phase II of the trial. Therefore, three biopsies
will be obtained at identical time points between the
treatment arms to assess relative glycogen resynthesis
rates during recovery and their degradation rates
during the subsequent exercise bout. To achieve the
aforementioned aims, the biopsy time points will be:
following the first exhaustive run, at the end of the
four hour recovery period and upon cessation of the
subsequent run to exhaustion.
A needle biopsy technique [57] will be used to obtain
approximately 30 to 100 mg of wet muscle tissue from the
vastus lateralis. This specific site was chosen: (1) to present
muscle glycogen data that are comparable with the majority
of investigations conducted in this area; and (2) because
of the large contribution of the quadriceps muscles during
treadmill running. Although it was demonstrated that
muscle glycogen utilisation is greater in the calf muscles
than in the thigh muscles [58], it is clear that substantial de-
pletion of muscle glycogen in the quadriceps is present dur-
ing treadmill running [38] Thus, measurements obtained
from the vastus lateralis were assumed to reflect the total
contribution of muscle glycogen towards overall metabol-
ism under the assumption that dry muscle mass of both
legs was 5% of body mass and that glycogen utilisa-
tion of these limbs is represented by the vastus lateralis
sample. Each muscle sample will be taken from a
different 3 to 5 mm skin incision site separated by 2
to 3 cm and applied under a local anaesthetic (2 to
3 ml of 1% lidocaine, Hameln Pharmaceuticals Ltd.,
Brockworth, UK) while participants were in a semi-
supine position. An opposite leg will be used during
the second main trial for each participant, where the use of
dominant/non-dominant limbs will be counterbalanaced
between participants.
Muscle biopsy analysis
Once removed from the leg, the muscle tissue will be
extracted immediately from the needle biopsy and snap-
frozen into liquid nitrogen. The muscle samples will then
be removed and placed in a cryogenic vial (Corning,
Ewloe, UK) while being maintained in liquid nitrogen
where they will be subsequently stored at −80°C pending
analysis for muscle glycogen concentrations determined
spectrophotometrically [59].Decontamination procedures
Once the wet muscle tissue extraction process has been
completed, all equipment used in the muscle biopsy tech-
nique will undergo a generic decontamination procedure.
All muscle biopsy component parts will be disassembled
and cleaned individually with warm water. A wire brush
will then be used to remove any organic matter, blood or
any other deposits prior to being placed in an Ultrasonic
bath containing a solution of 0.3% Sonozyme enzymatic
soap for sonification for 10 minutes at 30°C. Once soni-
fied, all equipment will be rinsed with ultrapure water be-
fore being immersed in a disinfectant (Milton Sterilising
Tablets, Newmarket, UK) for 15 minutes before another
rinse cycle with deionised ultrapure water. Finally, each
item will be individually placed in a sterilising pouch prior
to an autoclave at 121°C for 20 minutes.
Subjective measurements
Subjective RPEs will be obtained during all exercise trials
by using Borg’s 6 to 20 RPE scale [49], where 6 and 20
range from ‘very very light’ to ‘maximum’ effort. Subjective
measurements of stomach discomfort, gut fullness and
thirst will be recorded using adapted Borg scales in which
scales ranged from ‘no discomfort’ to ‘extreme discomfort’,
‘not full’ to ‘very very full’ and ‘not thirsty’ to ‘very very
thirsty’, respectively. To account for any mood distur-
bances during any experiments, a POMS questionnaire
will be completed by each participant prior to commen-
cing any of the trials. This questionnaire has been
shown to be a viable tool to detect any mood fluctuations
in an exercise setting that may have an influence on
performance [60,61].
Reliability measurements
To evaluate the error variation and establish sufficient
precision of measurement, coefficients of variation
(CV = SD/mean × 100) will be assessed for intra-assay
and intra-gas variations upon the attainment of data
from our procedures.
Statistical analysis
While the primary outcome measure in these experi-
ments is the rate of muscle glycogen resynthesis/degrad-
ation, this variable is highly reliable relative to other
outcomes and, accordingly, this consistency results in
sample size estimates requiring only four or five partici-
pants (thus justifying the use of typically six or eight par-
ticipants in most studies in this field). It was, therefore,
deemed appropriate to base sample size estimates on
secondary, less reliable, outcome measures. In this case,
exercise capacity exhibits the highest between subject
variability and our previous work that contributes dir-
ectly to the rationale for this study observed a difference
between the high sucrose and moderate sucrose plus
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7.5 minutes, with a standard deviation of differences of
5 minutes [21]. Based upon these data, it can be esti-
mated that a sample size of seven would be appropriate
even to provide a 90% power to detect such effects on
these more variable secondary outcomes using a two
tailed paired t-test.
A paired t-test will be used to compare between treat-
ments for the primary and secondary outcomes of the
study (that is, glycogen resynthesis/degradation and run
times to exhaustion). A two-way linear mixed model with
repeated measures (beverage × time) will be employed to
analyse the repeated experimental conditions. Mauchly’s
test will be used for sphericity. Where asphericity is as-
sumed, the Greenhouse-Geisser correction will be used
for epsilon <0.75 and Huynh-Feldt will be adopted for less
severe asphericity. Where significant F values are found a
Bonferroni step-wise correction will be employed to deter-
mine the location of the variance [62]. Simple summary
statistics will be used to inform interesting questions re-
lated to certain metabolites (for example, plasma glucose)
following each feeding strategy and during the subsequent
exhaustive bout. Statistical procedures were performed
using commercially available software (IBM SPSS version
20.0, SPSS Inc., Chicago, IL, USA) and significance is set
at an alpha level of 0.05. All results will be reported as the
mean ± standard deviation (SD) of the mean unless stated
otherwise.
Discussion
It remains to be established whether the provision of dif-
ferent amounts of carbohydrate to restore muscle glyco-
gen during short-term recovery may indeed translate into
a dose–response relationship with subsequent endurance
capacity. Although a dose–response has been independ-
ently observed in muscle glycogen restoration [22] and
subsequent endurance capacity [21] following an initial
exercise bout, no study has directly examined the associ-
ated links between these variables in a single cohort of
participants. The aim of Phase I of the trial is to examine
these effects.
Furthermore, the mechanism(s) for the potential im-
provements in the restoration of exercise capacity with
protein co-ingestion, in addition to establishing the likely
cause(s) of fatigue during a subsequent bout, remain to be
elucidated. Noticeably, further studies that mimic human
locomotion (that is, running-based studies) investigating
the area of post-exercise short-term recovery nutrition
need to be conducted. Interestingly, an improvement in
subsequent endurance capacity with protein feeding was
shown, irrespective of the fact that the glycogen levels were
similar to an isocaloric supplement [63]. Albeit in that
study, independent groups were used to assess glycogen re-
synthesis rates and endurance capacity. To our knowledge,no study concurrently explored the aforementioned fac-
tors. Therefore, the effects of nutrient intake/composition
upon limited recovery and the capacity for repeated exer-
cise requires further investigation. The current project
aims to contribute in further understanding of the mecha-
nisms of fatigue and the potential role of muscle glycogen
during a subsequent exercise bout following short-term
recovery and to establish any mediating effects of different
nutrient amounts and/or compositions to enhance recov-
ery of human endurance capacity.
Trial status
Data collection from Phase I is close to completion.
Participant recruitment is ongoing for Phase II coexistent
with data collection.
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